Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 266: C771-C775, 1994;
0363-6143/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izzo, N. J.
Right arrow Articles by Colucci, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izzo, N. J., Jr
Right arrow Articles by Colucci, W. S.

AJP - Cell Physiology, Vol 266, Issue 3 C771-C775, Copyright © 1994 by American Physiological Society

ARTICLES

Regulation of alpha 1B-adrenergic receptor half-life: protein synthesis dependence and effect of norepinephrine

N. J. Izzo Jr and W. S. Colucci
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Agonist-mediated down-regulation of alpha 1B-adrenergic receptors (AAR) may involve a decrease in synthesis, an increase in degradation, or a combination of the two mechanisms. Norepinephrine (NE) causes downregulation of AAR in rabbit aortic smooth muscle cells (RbSMC). To study the role of receptor degradation in this phenomenon, we studied the half-life (t1/2) of the AAR under basal conditions and during exposure to NE. We first determined the disappearance rate of AAR in the presence of cycloheximide, a commonly used method for measuring receptor t1/2. By this approach, the basal t1/2 was surprisingly long, 172 +/- 20 h. In contrast, the t1/2 in NE-treated cells was 11.8 +/- 0.3 h, suggesting that either NE decreased the t1/2 of AAR or cycloheximide increased the basal t1/2. To distinguish these possibilities, basal receptor t1/2 was determined by a second, independent method based on the repopulation of AAR after irreversible alkylation with chloroethylclonidine. This approach indicated a basal t1/2 (7.4 +/- 0.2 h) that was similar to the t1/2 with NE but more than 20-fold shorter than the t1/2 with cycloheximide. We conclude that in RbSMC NE-induced downregulation of AAR occurs without a decrease in receptor t1/2. The unexpected finding that cycloheximide markedly increases the basal t1/2 of the AAR further indicates that the t1/2 of the AAR is regulated, at least in part, by a short-lived protein that may regulate and/or mediate receptor degradation.


This article has been cited by other articles:


Home page
 IOVSHome page
G. Cui, W. L. Dean, and N. A. Delamere
The Influence of Cycloheximide on Na,K-ATPase Activity in Cultured Human Lens Epithelial Cells
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2714 - 2720.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Abdelaziz, F. Colombo, I. Mercier, and A. Calderone
Nitric Oxide Attenuates the Expression of Transforming Growth Factor-{beta}3 mRNA in Rat Cardiac Fibroblasts via Destabilization
Hypertension, August 1, 2001; 38(2): 261 - 266.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. A. Heck and D. B. Bylund
Mechanism of Down-regulation of Alpha-2 Adrenergic Receptor Subtypes
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1219 - 1227.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
R. M. Graham, D. M. Perez, J. Hwa, and M. T. Piascik
{alpha}1-Adrenergic Receptor Subtypes : Molecular Structure, Function, and Signaling
Circ. Res., May 1, 1996; 78(5): 737 - 749.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online